Higher lipoprotein(a) levels are associated with continuously increasing risk of recurrent atherosclerotic cardiovascular disease events, regardless of sex and race/ethnicity.

In this article, a novel interturn short-circuit fault (ISCF) diagnosis approach using an attention-based recurrent neural network is proposed. An encoder-decoder architecture using an attention ...

Correspondence to Dr Adam S Arthur, UT Department of Neurosurgery/Semmes-Murphey Clinic, Memphis TN 38120, USA; aarthur{at}semmes-murphey.com cSDHs have a tendency to ...

The optimal duration of hemostatic compression post transradial access is controversial. Longer duration increases the risk of radial artery occlusion (RAO) while shorter duration increases the risk ...

New data on the epidemiology of peripheral artery disease (PAD) are available, and they should be integrated with previous data. We provide an updated, integrated overview of the epidemiology of PAD, ...

During neck dissection aberrant branching of the common carotid artery (CCA) was noted consisting on a carotid ‘trifurcation’ with the internal carotid artery (ICA) coursing posterolaterally, the ...

Background Femoral access is the traditional approach for endovascular carotid artery stenting. Radial access is increasingly used as an alternative approach due to its known anatomical advantages in ...

aut.ac.nz Background Recurrent instability following a first-time anterior traumatic shoulder dislocation may exceed 26%. We systematically reviewed risk factors which predispose this population to ...

A radial scar, sometimes referred to as a complex sclerosing lesion, is a type of breast mass that may be associated with a slightly increased risk of breast cancer. Limited research suggests that ...

Prostate cancer that returns after treatment is called recurrent prostate cancer. Prostate cancer returns for a couple of reasons: Some cancer cells were left behind after surgery or radiation ...

The combination of avutometinib and defactinib is the first FDA-approved treatment for KRAS-mutated recurrent LGSOC. Approval was based on the phase 2 RAMP-201 trial, showing a 44% overall ...